Combinatorial

Identification of Combinatorial Genomic Abnormalities Associated with Prostate …
Multiple biomarkers are needed to distinguish aggressive from indolent prostate cancer. We tested the prognostic utility of a three-marker fluorescent in situ hybridization panel (TMPRSS2/ERG rearrangements, AR gain, and PTEN deletion) in a ... [...]
2
Like
Save